Washington, November 17 (RHC)-- U.S. President Donald Trump has nominated Alex Azar, a former top executive of pharmaceutical giant Eli Lilly, to lead the Department of Health and Human Services. The post has been vacant since the resignation of Tom Price.
Public Citizen’s Robert Weissman criticized the nomination, saying: “Tom Price supported Big Pharma in the U.S. Congress. Now apparently Trump has decided to cut out the middleman and let a pharmaceutical executive literally run the federal department that protects the health of all Americans.”
Donald Trump Nominates Former Drug Company Executive as HHS Secretary
Facebook
Twitter
Pinterest
Telegram
Linkedin
WhatsApp
Related Articles
Commentaries
MAKE A COMMENT
All fields required
More Views
- The world celebrates the decision of the United States on Cuba and demands an end to the blockade
- Statement of Cuban Foreign Ministry on removing island from State Department list of countries sponsoring terrorism
- Brazil announces Cuba, Bolivia and seven other countries as members of the BRICS group
- ExxonMobil countersues California attorney general and environmentalists over plastic pollution claims
- Cuba formally joins South Africa's lawsuit against Israel for genocide in Palestine
